BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>XPER selling Perceive is of greater benefit than the proceeds XPER would immediately receive. </li>
<li>The sale of Perceive to AMZN gives clarity as to the value of the technology XPER has been incubating for many years. </li>
<li>We estimate XPER recognizes approximately $3.5 million to $4 million in quarterly operating losses from Perceive. The cost savings would be material to XPER’s non-GAAP net income.</li>
</ul>


XPER selling Perceive is of greater benefit than the proceeds XPER would immediately receive. 
The sale of Perceive to AMZN gives clarity as to the value of the technology XPER has been incubating for many years. 
We estimate XPER recognizes approximately $3.5 million to $4 million in quarterly operating losses from Perceive. The cost savings would be material to XPER’s non-GAAP net income.


Xperi

XPER: Cash and Cost Savings